13F COMBINATION REPORT
TPG GP A, LLC
Quarter ended Q4 2025 · Filed February 13, 2026 · Accession 0001999371-26-003325
Total Value
$2.69B
Positions
10
Other Managers
0
Confidential Omitted
No
Holdings (10)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | LifeStance Health Group Inc | LFST | 160,711,618 | $1.13B | 42.11% |
| 2 | Life Time Group Holdings Inc | LTH | 17,830,652 | $473.9M | 17.64% |
| 3 | BETA Technologies Inc | BETA | 16,395,435 | $462.5M | 17.22% |
| 4 | Sionna Therapeutics Inc | SION | 6,744,962 | $277.5M | 10.33% |
| 5 | Amneal Pharmaceuticals Inc | AMRX | 12,328,767 | $155.3M | 5.78% |
| 6 | CeriBell Inc. | CBLL | 3,967,422 | $87.0M | 3.24% |
| 7 | Bicara Therapeutics Inc. | BCAX | 3,010,425 | $50.7M | 1.89% |
| 8 | Allogene Therapeutics Inc | ALLO | 18,716,306 | $25.6M | 0.95% |
| 9 | TPG RE Fin Tr Inc | TPGXL | 2,392,863 | $20.6M | 0.77% |
| 10 | Rallybio Corp | RLYB | 3,028,414 | $2.1M | 0.08% |